Biopharma Acquisitions Biopharma merger and acquisition value for the second quarter of 2022 reached $25.4bn from 36 transactions, 20 of which had disclosed values. Four M&A transactions hit or exceed
Investment firm Permira has signed an agreement to acquire a majority stake in orthopedics firm Corin Group PLC from a syndicate of investors including DeA Capital Alternative Funds SGR (controlled
The four board members who voted Arcturus Therapeutics Inc. founder Joseph Payne out of the RNA drug development firm at the end of January have been replaced under a settlement between the executiv
Epigenomics CEO German-US molecular diagnostics company Epigenomics AG has appointed Gregory Hamilton as its new CEO. Hamilton succeeds Thomas Taapken , who served as both CEO and chief financi